We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Tara Austraat-Churik, Partner at Blue Matter Consulting. Her background spans IBM Watson Health, where she led $50M+ enterprise deals during the first AI wave in pharma, EY’s Health Science and Wellness practice, an MSc in Translational Medicine from Edinburgh, and time as an FBI intelligence analyst. She calls it “Compound Expertise” — depth earned across domains that produces a kind of judgment no single career path can replicate.
In this episode, I sit down with Austraat-Churik and dig into how traditional life science companies compete when AI-native tech companies start discovering drugs without being pharma companies at all.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- How did you end up doing consulting like this?
- Tell me about value creation in the work you do.
- Are you more of a horizontal AI person, or is there a particular therapeutic area that’s a sweet spot for you?
- What is your moat?
- Trust or scale – what do you think is more important and keeps people coming back to you?
- How many people are on your team?
- Is this more of a corporate initiative or more of a local initiative?
- Techbio companies are now moving up the value chain to develop their own molecules and pipelines. What is your take on this? Is it a trend? What are companies doing? How are pharma/biotech companies dealing with this when computational/AI companies start stealing their turf? How does that work?
- What is the biggest anti-pattern in your industry?
- Will we see a vertically integrated techbio company that does everything?
Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.
Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
No comments:
Post a Comment